RE: Momentous day on the journey28 Jul 2022 10:24
I liked the '120 people in Manchester' bit. It shows confidence, going forward. 'Provided satisfactory safety data is obtained from this initial study, and subject to additional funding, a Phase 1b clinical study will commence in psoriasis patients in 2023. The CRO conducting and managing the studies has extensive experience in conducting trials in inflammatory diseases and will recruit up to 120 subjects at a site in Manchester, UK. '